Stockreport

Hims & Hers falls 8% after Novo's legal threat. Here's the latest [CNBC]

Novo Nordisk A/S  (NVO) 
Last novo nordisk a/s earnings: 2/5 01:31 am Check Earnings Report
US:NYSE Investor Relations: novonordisk.com/investors.html
PDF Hims is launching its pill for as little as $49, significantly lower than the $149 Novo sells the branded pill for. Hims is a volatile stock, inherently tied to its p [Read more]